Skip to main content
. 2022 Mar 9;13(6):1011–1020. doi: 10.1111/jdi.13750

Figure 3.

Figure 3

Number of type 2 diabetes patients who were prescribed sodium–glucose cotransporter 2 inhibitor (SGLT2i), including in a recent month.